Development of 125I-methylene blue for sentinel lymph node biopsy

Journal of Surgical Oncology

Volumn 94, Issue 4, 2006, Pages 293-297

  Stafford, Shawn J ^a   Wright, Jessica L ^a   Schwimer, Joshua ^a   Anthony, Catherine T ^a   Cundiff, Jason D ^a   Thomson, Jessica L ^a,b   Wang, Yi Zarn ^a   Espenan, Gregory ^a   Maloney, Thomas ^c   Camp, Arthur ^c   Woltering, Eugene A ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c Iso Tex   (United States)

Author keywords

Breast cancer; Iodine; Lymph nodes; Lymphazurin blue; Lymphoscintigraphy; Melanoma; Methylene blue; Radioisotope; Sentinel node biopsy

Indexed keywords

IODINE 125; METHYLENE BLUE; TECHNETIUM 99M; DIAGNOSTIC AGENT; RADIOACTIVE IODINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG UPTAKE; FOOT PAD; INGUINAL REGION; ISOTOPE LABELING; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHATIC SYSTEM; NONHUMAN; PRIORITY JOURNAL; RABBIT; RADIOACTIVITY; SENTINEL LYMPH NODE BIOPSY; ANIMAL; INJECTION; LYMPHADENECTOMY; METHODOLOGY; PATHOLOGY; SCINTISCANNING;

ANIMALS; INJECTIONS; IODINE RADIOISOTOPES; LYMPH NODE EXCISION; LYMPH NODES; METHYLENE BLUE; RABBITS; SENTINEL LYMPH NODE BIOPSY;

EID: 33748298788     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20444     Document Type: Article

References (28)

1. Halsted WS: The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June 1889 to January 1894. Johns Hopkins Hosp Bull 1894;4:297.
2. Jamali FR, Kurtzman SH, Deckers PJ: Role of axillary dissection in mammographically detected breast cancer. Surg Oncol Clin N Am 1997;6:343.
3. Kett K, Varga G, Lukács L: Direct lymphography of the breast. Lymphology 1970;1:3.
4. Fee HJ, Robinson DS, Sample WF, et al.: The determination of lymph shed by colloidal gold scanning in patients with malignant melanoma: A preliminary study. Surgery 1978;84:626.
5. Haagensen CD: Lymphatics of the breast. In: Haagensen CD, Feind KR, Herter FP, Slanetz CA, Weinberg JA, editors. The Lymphatics in Cancer. Philadelphia: WB Saunders Company; 1972. 300-387.
6. Weissbach L, Boedefeld EA: Localization of solitary and multiple metastases in stage II nonseminomatous testis tumor as basis for a modified staging lymph node dissection in stage I. J Urol 1987; 138:77.
7. Krag DN, Weaver DL, Alex JC, et al.: Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993;2:335.
8. Giuliano AE, Kirgan DM, Guenther JM, et al.: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391.
9. Giuliano AE, Haigh PI, Brennan MB, et al.: Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 2000;18:2553.
10. Hsueh EC, Turner RR, Glass EC, et al.: Sentinel node biopsy in breast cancer. J Am Coll Surg 1999;189:207.
11. Albertini JJ, Lyman GH, Cox C, et al.: Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996;276:1818.
12. Krynyckyi BR, Kim CK, Mosci K, et al.: Areolar-cutaneous "junction" injections to augment sentinel node count activity. Clin Nucl Med 2003;28:97.
13. Lloyd LR, Wesen CA, McCallum S: An analysis of filtration and volume of radionucleotide in sentinel lymph node biopsy in breast cancer patients. Am Surg 2002;68:373. Discussion 375-376.
14. 125Iodine labeled lanreotide and intraoperative gamma detection. Surgery 1994;116:1139.
15. 125I-lanreotide in women with primary breast cancer. Ann Surg Oncol 1999;6:367.
16. Haddad R, Avital S, Troitsa A, et al.: Benefits of radio-immunoguided surgery for pelvic recurrence. Eur J Surg Oncol 2001;27:298.
17. Zerwes FP, Frasson AL, Gutfilen B, et al.: Identification of sentinel node in breast cancer. J Exp Clin Cancer Res 2002;21:155.
18. Aras G, Arican P, Cam R, et al.: Identification of sentinel lymph node in breast cancer by lymphoscintigraphy and surgical gamma probe with peritumoral injection of scintimammographic agent "99mTc MIbI". Ann Nucl Med 2002;16:121.
19. Bembenek A, Reuhl T, Markwardt J, et al.: Sentinel lymph node dissection in breast cancer. Swiss Surg 1999;5:217.
20. Krag DN, Harlow S, Weaver D, et al.: Radiolabeled sentinel node biopsy: Collaborative trial with the National Cancer Institute. World J Surg 2001;25:823.
21. Harlow SP, Krag DN, Ashikaga T, et al.: Gamma probe guided biopsy of the sentinel node in malignant melanoma: A multicentre study. Melanoma Res 2001;11:45.
22. Gogel BM, Kuhn JA, Ferry KM, et al.: Sentinel lymph node biopsy for melanoma. Am J Surg 1998;176:544.
23. Rubio IT, Korourian S, Cowan C, et al.: Sentinel lymph node biopsy for staging breast cancer. Am J Surg 1998;176:532.
24. Krag D, Weaver D, Ashikaga T, et al.: The sentinel node in breast cancer-a multicenter validation study. N Engl J Med 1998; 339:941.
25. Gulec SA, Moffat FL, Carroll RG, et al.: Sentinel lymph node localization in early breast cancer. J Nucl Med 1998;39:1388.
26. Alex JC, Krag DN, Harlow SP, et al.: Localization of regional lymph nodes in melanomas of the head and neck. Arch Otolaryngol Head Neck Surg 1998;124:135.
27. Motomura H, Ishii M: Lymphatic mapping and sentinel lymph node biopsy for malignant melanoma in Japanese. Osaka City Med J 2004;50:29.
28. Stratmann SL, McCarty TM, Kuhn JA: Radiation safety with breast sentinel node biopsy. Am J Surg 1999;178:454.